The Food and Drug Administration on Friday approved the first-ever drug to treat children for peanut allergies, The Washington Post reports. The drug, Palforzia, is made of peanut protein, and will be fed to kids ages 4 to 17 in gradually increasing doses. In tests, two-thirds of patients were able to safely consume two peanuts after a year of treatment.
Still, there are caveats: The drug cannot be considered a cure, is not likely to provide a solution for everyone, and also costs $890 per month. And some allergists say that the drug’s manufacturer, Aimmune Therapeutics, is spinning a silk purse out of a sow’s ear. Doctors already offer the same therapy by feeding patients small amounts of peanut flour, which retails for $6 a pound.
Grist, an award-winning, nonprofit media organization dedicated to highlighting climate solutions and uncovering environmental injustices,…
Every year, California dairy farms emit hundreds of thousands of tons of the potent greenhouse…
Highway 7 runs north-south through western Washington, carving its way through a landscape sparsely dotted…
One of the greatest pleasures I had as a child growing up in the Chicago…
Undocumented immigrants experience food insecurity at much higher rates than other populations, yet they are…
Writer Charlotte Druckman and editor Rebecca Flint Marx are both Jewish journalists living in New…